The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LUNA: A randomized phase II trial of liver resection plus chemotherapy or chemotherapy alone in patients with unresectable lung and resectable liver metastases from colorectal adenocarcinoma.
 
Yun Shin Chun
No Relationships to Disclose
 
Reza J. Mehran
No Relationships to Disclose
 
Ching-Wei David Tzeng
No Relationships to Disclose
 
Bryan K. Kee
No Relationships to Disclose
 
A. Dasari
No Relationships to Disclose
 
Boris Sepesi
No Relationships to Disclose
 
Claudius Conrad
No Relationships to Disclose
 
Thomas A. Aloia
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Genentech; Merrimack; MolecularMatch; Roche; Sanofi; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Jean-Nicolas Vauthey
No Relationships to Disclose